Levi & Korsinsky, LLP Notifies Investors in FTAI Aviation Ltd. of Class Action Securities Lawsuit Overview On February 7, 2025, Levi & Korsinsky, LLP announced the notification of investors in FTAI Aviation Ltd. (“FTAI Aviation” or the “Company”) (NASDAQ: FTAI) regarding a class action securities lawsuit. The lawsuit alleges certain violations of securities laws by…
Levi & Korsinsky, LLP Notifies Investors in Pacira BioSciences, Inc. of Class Action Lawsuit Date: February 7, 2025 New York – Levi & Korsinsky, LLP has recently notified investors in Pacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) of a class action securities lawsuit. The lawsuit aims to recover losses on behalf of Pacira…
Investors Beware: BioAge Labs Faces Class Action Securities Lawsuit A Funny Look at the Serious Side of Securities Fraud It’s a bird, it’s a plane, it’s…BioAge Labs? Well, not quite. This biotech company may have soared high in the eyes of investors, but it seems like they’ve hit a bit of turbulence with a class…
Recent Class Action Lawsuit Alert: Kyverna Therapeutics, Inc. In a recent announcement, Levi & Korsinsky, LLP has notified investors in Kyverna Therapeutics, Inc. (“Kyverna Therapeutics, Inc.” or the “Company”) (NASDAQ: KYTX) of a class action securities lawsuit. This lawsuit seeks to recover losses on behalf of Kyverna Therapeutics, Inc. investors who were allegedly affected by…
Investors Beware: ModivCare Faces Class Action Lawsuit Hey there, fellow investors! Are you one of the unfortunate souls who put their hard-earned money into ModivCare Inc. (“ModivCare”) between November 3, 2022 and September 15, 2024? Well, I hate to break it to you, but you might be in for a wild ride. Levi & Korsinsky,…
Investors Beware: Regeneron Pharmaceuticals, Inc. Faces Class Action Lawsuit Introduction NEW YORK, Feb. 7, 2025 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) of a class action securities lawsuit. The lawsuit seeks to recover losses on behalf of Regeneron investors who were adversely affected by…
URTH: Navigating the World of GDP Projections and Stock Market Performance Understanding the Complexities of URTH’s Price URTH’s price is closely tied to various factors such as GDP projections, EPS estimates, and overall stock market performance. In fact, a 2025 global GDP growth estimate of 3.3% and U.S. GDP at 2.7% are key indicators that…
The Rise of Toast Stock in 2025 Toast Stock Surges in 2024 Toast (TOST 1.60%) stock nearly doubled last year, showing an impressive growth trajectory that has continued into the new year. Investors have been thrilled with the performance of Toast, as it has consistently outdone the S&P 500 with its impressive gains. Strong Start…
